Voyager Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Voyager Therapeutics (Nasdaq: VYGR) announced its participation in two upcoming virtual investor conferences. The first is the Wedbush PacGrow Healthcare Conference, featuring a panel discussion on August 11, 2021, at 8:35 AM ET. The second is the Canaccord Genuity Growth Conference, which includes a fireside chat on August 12, 2021, from 10:30 to 10:55 AM ET. Investors can access these sessions via the Investors & Media section of Voyager’s website. The company focuses on advancing AAV gene therapy to treat serious diseases using its TRACER™ screening platform.

CAMBRIDGE, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments and next-generation platform technologies, today announced that it will participate in the following upcoming virtual investor conferences.

• Wedbush PacGrow Healthcare Conference, panel discussion, August 11, 2021, 8:35 AM ET.
• Canaccord Genuity Growth Conference, fireside chat, August 12, 2021, 10:30-10:55 AM ET.

The sessions may be accessed from the Investors & Media section of Voyager’s website at www.voyagertherapeutics.com. Replays of the webcasts will be archived on the Company's website for at least 30 days.

About Voyager Therapeutics
Voyager Therapeutics (Nasdaq: VYGR) is leading the next generation of AAV gene therapy to unlock the potential of the technology to treat devastating diseases. Proprietary capsids born from the Company’s TRACER™ screening platform are powering a rich early-stage pipeline of new and second-generation programs and may elevate the field to overcome the limitations of conventional gene therapy vectors across neurological disorders and other therapeutic areas.

voyagertherapeutics.com LinkedIn Twitter

Investor Inquiries:        
investors@voyagertherapeutics.com

Media Inquiries:        
Scott Santiamo
ssantiamo@voyagertherapeutics.com

FAQ

What is Voyager Therapeutics announcing on August 10, 2021?

Voyager Therapeutics announced its participation in two virtual investor conferences, including the Wedbush PacGrow Healthcare Conference and the Canaccord Genuity Growth Conference.

When is the Wedbush PacGrow Healthcare Conference?

The Wedbush PacGrow Healthcare Conference is on August 11, 2021, at 8:35 AM ET.

What time is Voyager's fireside chat at the Canaccord Genuity Growth Conference?

Voyager's fireside chat at the Canaccord Genuity Growth Conference is scheduled for August 12, 2021, from 10:30 to 10:55 AM ET.

How can I access Voyager Therapeutics' investor conference sessions?

The investor conference sessions can be accessed through the Investors & Media section of Voyager Therapeutics' website.

What technologies does Voyager Therapeutics focus on?

Voyager Therapeutics specializes in AAV gene therapy, utilizing its TRACER™ screening platform to develop treatments for serious diseases.